The Turkish Journal of Pediatrics 2013 , Vol 55 , Num 5
Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey
1Division of Neonatology, Department of Pediatrics, McMaster University Hamilton, and 2Medical Outcomes and Research in Economics (MORE®), Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada. E-mail: Keywords : respiratory syncytial virus, prematurity, palivizumab, prophylaxis.
Copyright © 2016